Brandtree

Who owns Yescarta?

Yescarta is owned by Gilead (the United States, NASDAQ: GILD).[1]

Evidence: Gilead Sciences, Inc. Annual Report on Form 10-K filed 2026-02-24, SEC EDGAR, 24 February 2026. Verified from filings; last checked .

Key facts

Current owner
Gilead Sciences, Inc. verified
Owner HQ
🇺🇸 United States, Foster City
Origin
🇺🇸 United States
Category
Healthcare & pharma › Drug makers › Biotechnology
Parent ticker
NASDAQ: GILD
Last verified
· 1 sources

About Yescarta

Yescarta is a CAR T-cell therapy, axicabtagene ciloleucel, for adults with large B-cell lymphoma and follicular lymphoma. Gilead's 2025 10-K lists it as an oncology product and describes the chain-of-custody systems, such as Kite Konnect, that its cell therapies depend on.

Ownership timeline of Yescarta

  1. Current owner Gilead [1] verified

Where Yescarta sits in Gilead

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Yescarta sits in Gilead Tree of 9 brands under Gilead. Gilead Yescarta Biktarvy Descovy Epclusa Genvoya Sunlenca and 3 more

Open the full Gilead ownership tree →

See the full Gilead brand portfolio (9) →

Other brands owned by Gilead

Gilead controls 9 brands on Brandtree, 9 of them in healthcare & pharma.

Also in healthcare & pharma

All Gilead brands →

Other brands in drug makers, and who owns them

Gilead has more brands in drug makers on Brandtree than any other owner: 5 of 24.

BrandOwnerOwner based in
Amneal Amneal 🇺🇸 United States
Bemfola Richter 🇭🇺 Hungary
Ajovy Teva 🇮🇱 Israel
Celebrex Viatris 🇺🇸 United States
Habitrol Dr. Reddy's 🇮🇳 India
AvKARE Amneal 🇺🇸 United States
Brekiya Amneal 🇺🇸 United States
Rytary Amneal 🇺🇸 United States

Every brand in drug makers and its owner →

About the owner: Gilead

Gilead is a publicly listed company headquartered in Foster City, United States. Brandtree records 9 brands under its control, and it is listed as NASDAQ: GILD.

Gilead Sciences is a Delaware-incorporated biopharmaceutical company headquartered in Foster City, California. Its 10-K for 2025 says its commercial portfolio included more than 25 therapies in HIV, liver disease, oncology and other areas, sold through marketing subsidiaries in more than 35 countries, and records a 2020 acquisition of Immunomedics and the October 2025 acquisition of Interius BioTherapeutics.

Gilead: full profile, brands and acquisition history →

🇺🇸 Yescarta and other American brands

Brandtree records a controlling owner for 2,399 brands that began in the United States. 461 of them (19%) are now controlled by a company headquartered in another country; Yescarta is not one of them.

All American brands and who owns them →

Frequently asked questions

Who is the parent company of Yescarta?

The parent company of Yescarta is Gilead, a publicly listed company headquartered in the United States.

Is Yescarta American?

Yes. Yescarta originated in the United States and its owner, Gilead, is also headquartered in the United States.

Is Yescarta still owned by Gilead?

Yes. As of 14 October 2026, Yescarta is still owned by Gilead. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Gilead Sciences, Inc. Annual Report on Form 10-K filed 2026-02-24 — SEC EDGAR, SEC Form 10-K, published 24 February 2026; retrieved 14 October 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.